MODERATE EXERCISE DOES NOT IMPAIR THE EFFECT OF GLUCAGON IN INSULIN PUMP TREATED INDIVIDUALS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER STUDY: [Meeting Abstract}

I. Steineck; A. Ranjan; S. Schmidt; J. J. Holst; K. Norgaard

MODERATE EXERCISE DOES NOT IMPAIR THE EFFECT OF GLUCAGON IN INSULIN PUMP TREATED INDIVIDUALS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER STUDY: [Meeting Abstract}

I. Steineck, A. Ranjan, S. Schmidt, J. J. Holst, K. Norgaard

Endocrinology and Metabolism

Original language	English
Article number	072
Journal	Diabetes Technology & Therapeutics
Volume	20
Pages (from-to)	A35-A35
ISSN	1520-9156
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

MODERATE EXERCISE DOES NOT IMPAIR THE EFFECT OF GLUCAGON IN INSULIN PUMP TREATED INDIVIDUALS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER STUDY : [Meeting Abstract}. / Steineck, I.; Ranjan, A.; Schmidt, S. et al.

In: Diabetes Technology & Therapeutics, Vol. 20, 072, 2018, p. A35-A35.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

@article{58021d6334134f238ebb22b5216233e9,

title = "MODERATE EXERCISE DOES NOT IMPAIR THE EFFECT OF GLUCAGON IN INSULIN PUMP TREATED INDIVIDUALS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER STUDY: [Meeting Abstract}",

author = "I. Steineck and A. Ranjan and S. Schmidt and Holst, {J. J.} and K. Norgaard",

year = "2018",

language = "English",

volume = "20",

pages = "A35--A35",

journal = "Diabetes Technology & Therapeutics",

issn = "1520-9156",

publisher = "Mary AnnLiebert, Inc. Publishers",

}

TY - ABST

T1 - MODERATE EXERCISE DOES NOT IMPAIR THE EFFECT OF GLUCAGON IN INSULIN PUMP TREATED INDIVIDUALS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER STUDY

T2 - [Meeting Abstract}

AU - Steineck, I.

AU - Ranjan, A.

AU - Schmidt, S.

AU - Holst, J. J.

AU - Norgaard, K.

PY - 2018

Y1 - 2018

M3 - Conference abstract in journal

SN - 1520-9156

VL - 20

SP - A35-A35

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

M1 - 072

ER -